Avalo Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2015 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Avalo Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2015 to 2023.
  • Avalo Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 4.21 USD/shares.
  • Avalo Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 93.9 USD/shares.
  • Avalo Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -114 USD/shares.
  • Avalo Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.06K USD/shares.
  • Avalo Therapeutics, Inc. annual Earnings Per Share, Basic for 2018 was -1.2 USD/shares, a 386% decline from 2017.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$114 +$949 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$1.06K* Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2018 -$1 -$2 -386% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-18
2017 $0.42 +$2.29 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$2 +$2.84 +60.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$5 Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.